تخليق الإيبوبروفين — عملية BHC الخضراء

الكيمياء الخضراء الحائزة على جوائز في التصنيع الدوائي

Pharmaceutical & Drug Manufacturing Global Industrial Scale $1.5 billion

نظرة عامة

Ibuprofen is one of the most consumed non-steroidal anti-inflammatory drugs (NSAIDs) worldwide. The BHC Company (now BASF) developed a revolutionary three-step catalytic synthesis in the 1990s, replacing the original six-step Boots process. This green chemistry approach reduced waste by 99%, achieved near-perfect atom economy, and won the Presidential Green Chemistry Challenge Award in 1997. The process demonstrates how catalytic methods can transform pharmaceutical manufacturing.

العملية الكيميائية

Isobutylbenzene undergoes Friedel-Crafts acylation with acetic anhydride using HF catalyst, followed by hydrogenation over Pd/C, then carbonylation with CO using Pd catalyst to yield ibuprofen in three atom-efficient steps.

C₁₀H₁₄ + (CH₃CO)₂O →[HF] C₁₂H₁₆O + CH₃COOH
C₁₂H₁₆O + H₂ →[Pd/C] C₁₂H₁₈O
C₁₂H₁₈O + CO →[Pd] C₁₃H₁₈O₂

المواد الخام

  • Isobutylbenzene (C₁₀H₁₄) — Petrochemical synthesis (Starting material)
  • Acetic anhydride ((CH₃CO)₂O) — Ketene process (Acylating agent)
  • Carbon monoxide (CO) — Syngas (Carbonylation reagent)
  • Hydrogen gas (H₂) — Steam methane reforming (Reducing agent)

المنتجات النهائية

  • Ibuprofen (C₁₃H₁₈O₂) — NSAID analgesic and anti-inflammatory (Racemic mixture, >99% purity)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

The BHC process achieves 77% atom economy versus 40% for the original Boots process, dramatically reducing waste generation. HF catalyst is recycled with >99.9% recovery. The three-step process generates minimal aqueous waste compared to the six-step alternative.

اعتبارات السلامة

الابتكارات الحديثة

Asymmetric synthesis methods producing the more active S-(+)-ibuprofen enantiomer are under development, which would halve the required dose.
Continuous flow processes are being implemented to further improve safety and efficiency.

حجم الإنتاج

30000

طن/سنة

$1.5 billion

القيمة السوقية

المزيد في %(name)s Pharmaceutical & Drug Manufacturing

إنتاج الأموكسيسيلين شبه الصنعي

Global Industrial Scale

إنتاج الإنسولين البشري المؤتلف

Global Industrial Scale

إنتاج البنسلين G بالتخمير

Global Industrial Scale

تخليق أوميبرازول لمثبطات مضخة البروتون

Global Industrial Scale

تخليق الأسبرين عبر أستلة حمض الساليسيليك

Global Industrial Scale

تخليق الباراسيتامول (الأسيتامينوفين)

Global Industrial Scale

تخليق هيدروكلوريد الميتفورمين

Global Industrial Scale

Frequently Asked Questions

What industry uses تخليق الإيبوبروفين — عملية BHC الخضراء?
تخليق الإيبوبروفين — عملية BHC الخضراء is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in تخليق الإيبوبروفين — عملية BHC الخضراء?
Isobutylbenzene undergoes Friedel-Crafts acylation with acetic anhydride using HF catalyst, followed by hydrogenation over Pd/C, then carbonylation with CO using Pd catalyst to yield ibuprofen in three atom-efficient steps.
What is the economic significance of تخليق الإيبوبروفين — عملية BHC الخضراء?
تخليق الإيبوبروفين — عملية BHC الخضراء has a market value of $1.5 billion and annual production of 30,000 tons.
What is the environmental impact of تخليق الإيبوبروفين — عملية BHC الخضراء?
The BHC process achieves 77% atom economy versus 40% for the original Boots process, dramatically reducing waste generation. HF catalyst is recycled with >99.9% recovery. The three-step process generates minimal aqueous waste compared to the six-step alternative.
What raw materials are used in تخليق الإيبوبروفين — عملية BHC الخضراء?
The main raw materials include: Isobutylbenzene (C₁₀H₁₄), Acetic anhydride ((CH₃CO)₂O), Carbon monoxide (CO), Hydrogen gas (H₂).